Yes, Ozempic and other GLP-1 medications like Wegovy and Zepbound can cause significant muscle loss, especially in women over 40 who are already more prone to losing lean mass due to hormonal shifts and age-related sarcopenia
(4) McGuire FP, Martinez R, Lenz A, Skinner L, Cushman DM
Research has found that some drugs in these groups may lower the risk of heart disease, such as heart failure, stroke and kidney disease
Other GLP-1 Agents: Key Differences in Clinical Context Multiple GLP-1 receptor agonists exist, each with different pharmacokinetics, dosing schedules, and efficacy profiles
Individual safety depends on your health history, current conditions, and how your body responds to each medication
The top companies in this segment include Novo Nordisk, Eli Lilly, Merck, Sanofi, AstraZeneca and Boehringer Ingelheim